GENE ONLINE|News &
Opinion
Blog

GRAIL
Illumina Wins EU Court Battle, Dodges Fine, but Grail Deal Already Void
2024-09-05
GeneOnline’s Pick: Top 10 Global Industry News Stories in 2023 (Part 1)
2024-01-08
European Commission Prohibits Illumina’s Acquisition of GRAIL After The Company’s Win Against The FTC
2022-09-07
GeneOnline’s Top 10 M&As of 2021
2022-01-11
Illumina Completes GRAIL Acquisition Without Approval From FTC
2021-08-19
NHS To Trial GRAIL’s Blood Test That Can Accurately Detect Over 50 Cancers at Early Stages
2021-07-01
10 Precision Oncology Companies to Look Out for
2021-05-27
M&A
Amidst Battle with FTC, Illumina Faces Scrutiny from EU Over its $7.1B GRAIL Merger
2021-04-20
M&A
FTC Blocks Illumina’s $7 Billion Acquisition Bid to Restrict Monopoly of Cancer Diagnostic Market
2021-04-01
GeneOnline’s Top Mergers and Acquisitions of 2020
2020-12-30
Illumina Advances Talks to Acquire Healthcare Start-up Grail
2020-09-16
Cancer-Screening Startup GRAIL Files for IPO
2020-09-12
LATEST
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
Highlights from ESMO 2024: Key Oncology Advances from Major Pharmaceutical Companies
2024-09-19
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
2024-09-19
Biotech Industry Trends in 2024: A Look at the Billions in Oncology Deals
2024-09-18
Thailand’s Biotech Boom: Innovations in Precision Medicine, Cell Therapy, and Wellness Drive APAC Leadership
2024-09-18
International Green Party Showcases AI Solutions for a Healthy and Sustainable Future
2024-09-16
Bio Asia Pacific 2024 Close ASEAN Collaborations: Catalyzing Innovation and Global Partnerships
2024-09-12
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
Scroll to Top